Clariant AG (FRA:CLRN) Research & Development: €132 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CLRN Clariant AG FRA:CLRN
63 GF Score
Price €10.80
GF Value €9.73
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Clariant AG Research & Development?

Clariant AG FRA:CLRN +4.05% 63 Research & Development is €132 Mil as of Jun. 2026. GuruFocus rates FRA:CLRN with a GF Score™ of 63/100 and a GF Value™ of €9.73 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Clariant AG's Research & Development for the six months ended in Jun. 2026 was €70 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was €132 Mil.

Clariant AG  (FRA:CLRN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Clariant AG Research & Development Related Terms

Clariant AG Research & Development Historical Data

* Premium members only.

The historical data trend for Clariant AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariant AG Research & Development Chart

Clariant AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 148.94 162.13 169.66 134.96 133.96

Clariant AG Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.40 69.62 71.01 62.59 69.61
FRA:CLRN
63GF Score
Clariant AG FRA:CLRN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clariant AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €132 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €132 Mil mean?
Clariant AG (FRA:CLRN) has a Research & Development of €132 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Clariant AG and its competitors.
Is Clariant AG's Research & Development too high?
Clariant AG's current Research & Development is €132 Mil. Overall, Clariant AG has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariant AG's Research & Development compare to LIN and SHW?
Clariant AG's Research & Development of €132 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Clariant AG and its competitors. Clariant AG's current Research & Development is €132 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariant AG stock overvalued right now?
Based on GuruFocus' analysis, Clariant AG (FRA:CLRN) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.73, compared to a current price of €10.80 — trading 11% above its estimated fair value. The current Research & Development is €132 Mil. Clariant AG's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Clariant AG (FRA:CLRN), the current Research & Development is €132 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariant AG (FRA:CLRN) Overvalued in 2026?

Based on GuruFocus' analysis, Clariant AG stock appears to be overvalued. The current stock price of €10.80 is trading 11% above its estimated GF Value™ of €9.73. GuruFocus considers Clariant AG to be Modestly Overvalued.

Key valuation signals for FRA:CLRN:

  • Research & Development: €132 Mil
  • GF Value™: €9.73 vs. price of €10.80 (11% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the FRA:CLRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariant AG Business Description

Address Rothausstrasse 61, Muttenz, CHE, 4132
Clariant AG is a Switzerland-based specialty chemicals company with world-wide operations. It develops, manufactures, distributes, and sells a broad range of specialty chemicals, which play a key role in its customers' manufacturing and treatment processes or add value to their end products. The company reports in three business areas: care chemicals, absorbents and additives and catalysts. Care chemicals mainly targets consumer end markets such as personal care and homecare, but it also has an industrial component. Absorbents and additives encompass Clariant's coatings and adhesives, absorbents, and plastics segments. Catalysts manufacturers process catalysts, mainly for petrochemical and syngas plants.
63GF Score

Get the complete analysis for FRA:CLRN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80
Price
€9.73
GF Value